These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15800927)

  • 1. E1A-F is overexpressed early in human colorectal neoplasia and associated with cyclooxygenase-2 and matrix metalloproteinase-7.
    Boedefeld WM; Soong R; Weiss H; Diasio RB; Urist MM; Bland KI; Heslin MJ
    Mol Carcinog; 2005 May; 43(1):13-7. PubMed ID: 15800927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
    Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
    J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
    Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
    Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis.
    Nosho K; Yoshida M; Yamamoto H; Taniguchi H; Adachi Y; Mikami M; Hinoda Y; Imai K
    Carcinogenesis; 2005 May; 26(5):892-9. PubMed ID: 15695237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis.
    Hao X; Bishop AE; Wallace M; Wang H; Willcocks TC; Maclouf J; Polak JM; Knight S; Talbot IC
    J Pathol; 1999 Feb; 187(3):295-301. PubMed ID: 10398082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of colorectal cancer - role of gastrin and cyclooxygenase-2.
    Hartwich J; Konturek SJ; Pierzchalski P; Zuchowicz M; Konturek PC; Bielański W; Marlicz K; Starzyńska T; Ławniczak M
    Med Sci Monit; 2001; 7(6):1171-81. PubMed ID: 11687726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
    Takai T; Kanaoka S; Yoshida K; Hamaya Y; Ikuma M; Miura N; Sugimura H; Kajimura M; Hishida A
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1888-93. PubMed ID: 19505922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factor-kappa B regulates cyclooxygenase-2 expression and cell proliferation in human colorectal carcinoma tissue.
    Yu LL; Yu HG; Yu JP; Luo HS
    Eksp Onkol; 2004 Mar; 26(1):40-7. PubMed ID: 15112579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
    Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
    Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of 15-lipoxygenase-1 in human colorectal cancer.
    Ikawa H; Kamitani H; Calvo BF; Foley JF; Eling TE
    Cancer Res; 1999 Jan; 59(2):360-6. PubMed ID: 9927047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases.
    Zeng ZS; Shu WP; Cohen AM; Guillem JG
    Clin Cancer Res; 2002 Jan; 8(1):144-8. PubMed ID: 11801551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression.
    Elder DJ; Baker JA; Banu NA; Moorghen M; Paraskeva C
    J Pathol; 2002 Dec; 198(4):428-34. PubMed ID: 12434411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Cyclooxygenase expression and colorectal adenoma characteristics.
    Einspahr JG; Krouse RS; Yochim JM; Danenberg PV; Danenberg KD; Bhattacharyya AK; Martínez ME; Alberts DS
    Cancer Res; 2003 Jul; 63(14):3891-3. PubMed ID: 12873979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer.
    Lubbe WJ; Zhou ZY; Fu W; Zuzga D; Schulz S; Fridman R; Muschel RJ; Waldman SA; Pitari GM
    Clin Cancer Res; 2006 Mar; 12(6):1876-82. PubMed ID: 16551873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 expression is associated with increased size in human sporadic colorectal adenomas.
    Pisano C; Ottaiano A; Tatangelo F; Di Bonito M; Falanga M; Iaffaioli VR; Botti G; Pignata S; Acquaviva AM
    Anticancer Res; 2005; 25(3B):2065-8. PubMed ID: 16158946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
    Pesta M; Topolcan O; Holubec L; Rupert K; Cerna M; Holubec LS; Treska V; Finek J; Cerny R
    Anticancer Res; 2007; 27(4A):1863-7. PubMed ID: 17649785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of E1AF mRNA expression with tumor progression and matrilysin in human rectal cancer.
    Liu HY; Zhou B; Wang L; Li Y; Zhou ZG; Sun XF; Xu B; Zeng YJ; Song JM; Luo HZ; Yang L
    Oncology; 2007; 73(5-6):384-8. PubMed ID: 18511876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential stromal and epithelial localization of cyclooxygenase-2 (COX-2) during colorectal tumorigenesis.
    Arnoletti JP; Upson J; Babb JS; Bellacosa A; Watson JC
    J Exp Clin Cancer Res; 2005 Jun; 24(2):279-87. PubMed ID: 16110762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rofecoxib regulates the expression of genes related to the matrix metalloproteinase pathway in humans: implication for the adverse effects of cyclooxygenase-2 inhibitors.
    Wang XM; Wu TX; Lee YS; Dionne RA
    Clin Pharmacol Ther; 2006 Apr; 79(4):303-15. PubMed ID: 16580899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of cyclooxygenase-2 in renal cell carcinoma.
    Yoshimura R; Matsuyama M; Kawahito Y; Tsuchida K; Kuratsukuri K; Takemoto Y; Mitsuhashi M; Sano H; Nakatani T
    Int J Mol Med; 2004 Feb; 13(2):229-33. PubMed ID: 14719128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.